Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers. (Q53438825)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21310761 AND SRC:MED&resulttype=core&format=json

22 January 2020

title

Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21310761 AND SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

S Park

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21310761 AND SRC:MED&resulttype=core&format=json

22 January 2020

H S Park

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21310761 AND SRC:MED&resulttype=core&format=json

22 January 2020

J S Lee

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21310761 AND SRC:MED&resulttype=core&format=json

22 January 2020

J S Lee

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21310761 AND SRC:MED&resulttype=core&format=json

22 January 2020

S I Kim

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21310761 AND SRC:MED&resulttype=core&format=json

22 January 2020

B W Park

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21310761 AND SRC:MED&resulttype=core&format=json

22 January 2020

K S Lee

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21310761 AND SRC:MED&resulttype=core&format=json

22 January 2020

publication date

10 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21310761 AND SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21310761 AND SRC:MED&resulttype=core&format=json

22 January 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21310761 AND SRC:MED&resulttype=core&format=json

22 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21310761 AND SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

1755-1762

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21310761 AND SRC:MED&resulttype=core&format=json

The androgen receptor in breast cancer: learning from the past

22 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDQ678

Expression of androgen receptors in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDQ678

Triple-negative breast cancer: role of the androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDQ678

Androgen receptor as a target for the treatment of hormone receptor-negative breast cancer: an unchartered territory

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDQ678

Androgens and androgen receptors in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDQ678

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDQ678

Hormonal approaches in prostate cancer: application in the contemporary prostate cancer patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDQ678

Identification of molecular apocrine breast tumours by microarray analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDQ678

An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDQ678

A functionally significant cross-talk between androgen receptor and ErbB2 pathways in estrogen receptor negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDQ678

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDQ678

Combinatorial biomarker expression in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDQ678

Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDQ678

Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDQ678

Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDQ678

Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDQ678

Role of androgens on MCF-7 breast cancer cell growth and on the inhibitory effect of letrozole

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDQ678

Gene expression meta-analysis supports existence of molecular apocrine breast cancer with a role for androgen receptor and implies interactions with ErbB family

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDQ678

Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDQ678

Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDQ678

Breast cancer molecular class ERBB2: preponderance of tumors with apocrine differentiation and expression of basal phenotype markers CK5, CK5/6, and EGFR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDQ678

Chemistry and structural biology of androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDQ678